Member Directory
Norwich Research Park is one of five BBSRC funded UK Research and Innovation Campuses. It is the only site with three BBSRC funded research Institutes in the UK. The site also has a fourth research institute, a University, a University Hospital and a community of over 30 businesses.
Norwich Research Park offers businesses access to a specialist skills pool, and opportunities to collaborate and win global business at a unique research campus environment, with a community that is working together, as a powerful cluster of activity, specializing in food biotech, agricultural biotech and industrial biotech, applied to the effects of climate change and improvements to human health, using nature to solve the world’s problems.
Website: http://www.norwichresearchpark.com/
Contact: enquiries@norwichresearchpark.com
Watch our Member Showcase Video https://bit.ly/34Uy63y
Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. Nuclera is enabling life science researchers to obtain active proteins from DNA in 48 hours through its benchtop eProtein DiscoveryTM platform.
Website: www.nuclera.com
Contact: hello@nuclera.com
Watch our showcase video: https://www.nuclera.com/resource-library/video-intro-to-eprotein-discovery/
Heptares creates new medicines targeting previously undruggable or challenging GPCRs, a superfamily of receptors linked to many diseases. We are pioneering a structure-based drug design approach to GPCRs, leveraging proprietary technologies for protein stabilisation, structure determination, and fragment-based discovery. Our partners include Shire, AstraZeneca, MedImmune and Takeda. Our objective is to build a broad pipeline of novel medicines to transform the treatment of serious diseases, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression, chronic insomnia, addiction, migraine and diabetes.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.?
OncoLytika is an innovative technology development company with internal programmes ranging from veterinary medicine to drug delivery and medical imaging. These programmes are funded via OncoLytika's scientific and management consultancy services. We support preclinical drug development and diagnostic programs as well as drug delivery and imaging projects. We specialise in product diversification through innovation and partnering. We are leveraging our business planning, grant writing and R&D experience with our network of contacts across a diverse range of industrial, charitable and academic organisations to accelerate our development programmes and those of our partners.